The Curis presentation at the Wedbush conference starts in 10 min. The impact of the presentation and the phase I/II trial with a Swiss company are more important to hear about. Most posts seem foolish.
thanks to both of you, i missed it. that trial is u of mich cancer center/nci. hoping that he is not allowed to say anything about the triple comb gen/su2c/celgene trial.
Absolutely mentioned but not much depth.
sorry to have distracted you.
Slide 11:"Early Q3 prescription data shows encouraging growth"